Gaps and overlaps: Improving the current regulation of stem cells in the UK (editorial)

Leanne Bell; Sarah Devaney

doi:10.1136/jme.2007.022657

Gaps and overlaps: Improving the current regulation of stem cells in the UK (editorial)

Leanne Bell, Sarah Devaney

Law Department

Research output: Contribution to journal › Article

6 Citations (Scopus)

Abstract

A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK’s attempts to become a global leader in this field.

Original language	English
Pages (from-to)	621-622
Journal	Journal of Medical Ethics
Volume	33
Issue number	11
DOIs	https://doi.org/10.1136/jme.2007.022657
Publication status	Published - Nov 2007

Access to Document

10.1136/jme.2007.022657

Cite this

@article{177f0e54aca54f54a6a50ee600c408de,

title = "Gaps and overlaps: Improving the current regulation of stem cells in the UK (editorial)",

abstract = "A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK{\textquoteright}s attempts to become a global leader in this field.",

author = "Leanne Bell and Sarah Devaney",

year = "2007",

month = nov,

doi = "10.1136/jme.2007.022657",

language = "English",

volume = "33",

pages = "621--622",

journal = "Journal of Medical Ethics",

issn = "0306-6800",

publisher = "BMJ",

number = "11",

}

TY - JOUR

T1 - Gaps and overlaps: Improving the current regulation of stem cells in the UK (editorial)

AU - Bell, Leanne

AU - Devaney, Sarah

PY - 2007/11

Y1 - 2007/11

N2 - A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK’s attempts to become a global leader in this field.

AB - A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK’s attempts to become a global leader in this field.

U2 - 10.1136/jme.2007.022657

DO - 10.1136/jme.2007.022657

M3 - Article

SN - 0306-6800

VL - 33

SP - 621

EP - 622

JO - Journal of Medical Ethics

JF - Journal of Medical Ethics

IS - 11

ER -

Gaps and overlaps: Improving the current regulation of stem cells in the UK (editorial)

Abstract

Access to Document

Fingerprint

Cite this